Impact BioMedical, Inc. Cash Flow Quality Index

Latest as of September 2024: -0.30x

Impact BioMedical, Inc. cash flow quality index. Impact BioMedical, Inc. (IBO) has a Cash Flow Quality Index of -0.30x as of September 2024. Operating cash flow of $-1.74 Million is below net income of $5.74 Million, suggesting accrual-heavy earnings not yet converted to cash. See Impact BioMedical, Inc. (IBO) flexibility index to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-0.30x
Operating CF / Net Income

Operating Cash Flow

$-1.74 Million
USD

Net Income

$5.74 Million
USD

Data as of

Sep 2024
Most recent filing

Impact BioMedical, Inc. Cash Flow Quality Index by Year (None–None)

Impact BioMedical, Inc. cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Impact BioMedical, Inc.. For the full cash flow conversion analysis, see Impact BioMedical, Inc. cash conversion from operations.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.